Study of the Effects of PRALIA 60 mg Subcutaneous Injection Syringe on the Physical Functions, etc. of Rheumatoid Arthritis Patients
Not Applicable
Recruiting
- Conditions
- Rheumatoid arthritis
- Registration Number
- JPRN-jRCT2031210189
- Lead Sponsor
- Matsuoka Yomei
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 960
Inclusion Criteria
Initial examination, diagnosis of rheumatoid arthritis, receipt of a prescription for a DMARD (including biologics) during the enrollment period at the Kyoto University Hospital Rheumatic Disease Center
Exclusion Criteria
History of a bone or joint surgical procedure, receipt of a prescription for a RANKL inhibitor prior to the day of the initial examination at the Kyoto University Hospital Rheumatic Disease Center
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method